Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma Launches Its Semaglutide Injection Under Brand Names, Noveltreat And Sematrinity In India

March 20 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:

SUN PHARMA - LAUNCHES ITS SEMAGLUTIDE INJECTION UNDER BRAND NAMES, NOVELTREAT AND SEMATRINITY IN INDIA

SUN PHARMA - PHARMA LAUNCHES SEMAGLUTIDE INJECTION UNDER NOVELTREAT AND SEMATRINITY IN INDIA

SUN PHARMA - NOVELTREAT WEEKLY THERAPY COSTS 900 RUPEES-2,000 RUPEES; SEMATRINITY 750 RUPEES-1,300 RUPEES

SUN PHARMA - SEMATRINITY IS AVAILABLE IN TWO DOSE STRENGTHS - 2 MG/1.5 ML AND 4 MG/3 ML

SUN PHARMA: NOVELTREAT IS AVAILABLE IN FIVE DOSE STRENGTHS  0.25 MG/0.5 ML, 0.5 MG/0.5 ML, 1 MG/0.5 ML, 1.7 MG/0.75 ML, AND 2.4 MG/0.75 ML

Source text: ID:nBSE3g9RJQ

Further company coverage: SUN.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news